Stocks
Niagen Bioscience, Inc.NAGE
NASDAQHealthcareBiotechnology$2.50
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing therapies based on nicotinamide riboside, a form of vitamin B3. Its lead product candidate, Niagen, targets cellular metabolism and is being studied for conditions related to aging and metabolic health. Investors track the company for its progress in clinical trials and potential in the longevity and nutraceutical markets.
52W Range: $2.44-$7.95
Congressional Interest in Niagen Bioscience, Inc. (NAGE)
No congressional trades have been disclosed for Niagen Bioscience, Inc. (NAGE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading NAGE?
No congressional trades found for this stock.